题名 | Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data. |
作者 | Ferté C, Koscielny S, Albiges L, Rocher L, Soria JC, Iacovelli R, Loriot Y, Fizazi K, Escudier B. |
杂志 | Eur Urol. 2013 Aug 15. pii: S0302-2838(13)00831-2. doi: 10.1016/j.eururo.2013.08.010. [Epub ahead of print] |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/?term=Tumor+Growth+Rate+Provides+Useful+Information+to+Evaluate+Sorafenib+and+Everolimus+Treatment+in+Metastatic+Renal+Cell+Carcinoma+Patients%3A+An+Integrated+Analysis+of+the+TARGET+and+RECORD+Phase+3+Trial+Data |